Dr Markku Jalkanen has over 35 years of global experience in the pharmaceutical industry and has had senior leadership roles in the United States, Germany, France, the United Kingdom and the Nordic region.

The latest role he left in 2017 was as President of the Intercontinental region of Bristol Myers Squibb with responsibility for over 30 countries, 5,000 employees and a turnover of over 20 billion SEK. He is chairman of the board of BerGenBio, Norway and Farmalisto, Colombia. Anders is board member of Branding Science Ltd, UK and member of the Business Development and Launch Committee of the Board of Directors for Norgine. He holds a MSc in Pharmacy from Uppsala University.

Chairman of the Board
since 2018

Shares: 70,484

Independent in relation to the company and company management and major shareholders

/sites/faron-corp/files/image%204.png PhD - Chief Executive Officer Off